Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti · 2013
[Evaluation of the clinical results of implantation the hydrophobic-hydrophilic intraocular lens ERIFLEX 877 FAB].
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Stepanov A, Jirásková N, Nekolová J, Lackovič J, Románek J, Rozsíval P
Аннотация
PURPOSE: To evaluate the properties of intraocular lens ERIFLEX 877 FAB, the manipulation during implantation and clinical outcomes after implantation of the new hydrophobic-hydrophilic intraocular lens in patients undergoing routine cataract surgery.
MATERIAL AND METHODS: The study included 30 patients (38 eyes), mean age 71 ± 8 years (range 53-89 years) with senile cataract. After phacoemulsification intraocular lens ERIFLEX 877 FAB was implanted. Patients were evaluated at 3 months after surgery. We assessed the uncorrected visual acuity (UCVA) and best corrected visual acuity (BCVA), refraction, keratometry and the incidence of posterior capsule opacification (PCO - Posterior capsule opacification). Individual patients and surgeons satisfaction was also documented including manipulation during surgery.
RESULTS: Three months after surgery, the mean UCVA was 0.7 ± 0.2 and BCVA was 0.97 ± 0.16. PCO value was 0.15 ± 0.09, that means minimal incidence of PCO. Good UCVA and a minimal incidence of PCO have resulted in a high degree satisfaction of patients.
CONCLUSION: The new hydrophobic-hydrophilic intraocular lens ERIFLEX 877 FAB could be easily implanted and after surgery shows a high degree of biocompatibility in patients undergoing routine cataract surgery.
MATERIAL AND METHODS: The study included 30 patients (38 eyes), mean age 71 ± 8 years (range 53-89 years) with senile cataract. After phacoemulsification intraocular lens ERIFLEX 877 FAB was implanted. Patients were evaluated at 3 months after surgery. We assessed the uncorrected visual acuity (UCVA) and best corrected visual acuity (BCVA), refraction, keratometry and the incidence of posterior capsule opacification (PCO - Posterior capsule opacification). Individual patients and surgeons satisfaction was also documented including manipulation during surgery.
RESULTS: Three months after surgery, the mean UCVA was 0.7 ± 0.2 and BCVA was 0.97 ± 0.16. PCO value was 0.15 ± 0.09, that means minimal incidence of PCO. Good UCVA and a minimal incidence of PCO have resulted in a high degree satisfaction of patients.
CONCLUSION: The new hydrophobic-hydrophilic intraocular lens ERIFLEX 877 FAB could be easily implanted and after surgery shows a high degree of biocompatibility in patients undergoing routine cataract surgery.